Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

301/433 Matches for
“non-invasive markers of liver fibrosis and cirrhosis”

“non-invasive markers of liver fibrosis and cirrhosis” Clear all

  1. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.

    Sebastiani G et al. · World J Gastroenterol · 2007 Match 100

    ### Aim To assess the performance of several non-invasive markers and of…

    FibroTest HBV

  2. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

    Ahmad W et al. · Virol J · 2011 Match 100

    …on non-invasive methods currently available for predicting liver fibrosis in HCV…

    FibroTest HCV

  3. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.

    Lombardi R et al. · World J Gastroenterol · 2015 Match 100

    …non-invasive fibrosis markers have been suggested as alternatives to liver biopsy…

    FibroTest Alcohol

  4. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.

    Stasi C et al. · World J Gastroenterol · 2016 Match 100

    …and differentiating liver fibrosis. Finally, studies have shown that non-invasive methods…

    FibroTest HCV

  5. Concordance of non-invasive serology-based scoring indices and transient elastography for liver fibrosis and cirrhosis in chronic hepatitis C.

    Trnačević E et al. · Med Glas (Zenica) · 2021 Match 100

    …markers for significant liver fibrosis (METAVIR ≥F2), advanced liver fibrosis (≥F3) and…

    FibroTest HCV

  6. Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.

    Matta B et al. · Curr HIV/AIDS Rep · 2016 Match 100

    …Multiple non-invasive methods of liver fibrosis assessment have been developed, but…

    FibroTest HBV HCV HIV

  7. Non-invasive markers for hepatic fibrosis.

    Baranova A et al. · BMC Gastroenterol · 2011 Match 100

    …The rate of adoption of non-invasive diagnostic tests for liver fibrosis…

    FibroTest Alcohol HBV HCV +3

  8. The Diagnostic Value of FibroTest and Hepascore as Non-Invasive Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC).

    Cylwik B et al. · J Clin Med · 2023 Match 99

    …of two non-invasive, validated, and patented markers of liver fibrosis, the…

    FibroTest Other

  9. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.

    Parikh P et al. · Ann Transl Med · 2017 Match 99

    …The detection and quantification of liver fibrosis is a key factor for…

    FibroTest HBV

  10. Liver fibrosis markers in alcoholic liver disease.

    Chrostek L et al. · World J Gastroenterol · 2014 Match 99

    …Staging of liver fibrosis is essential to define prognosis and management of…

    FibroTest Alcohol

  11. Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study.

    Flores-Calderón J et al. · Ann Hepatol · 2012 Match 99

    …Utility of non-invasive markers of liver fibrosis has been proved in…

    FibroTest

  12. Noninvasive assessment of portal hypertension in patients with cirrhosis.

    Thabut D et al. · Hepatology · 2011 Match 99

    …and mainly involve the detection of hepatic fibrosis by serum markers and…

    FibroTest Alcohol HBV HCV +3

  13. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis.

    Friedrich-Rust M et al. · BMC Gastroenterol · 2010 Match 99

    …accuracy for the non-invasive staging of liver fibrosis. Serum tests are…

    FibroTest HBV HCV Other

  14. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.

    Schmid P et al. · PLoS One · 2015 Match 98

    …performance of seven non-invasive tests (NITs) of liver fibrosis and to…

    FibroTest HCV HIV

  15. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.

    Sebastiani G et al. · Aliment Pharmacol Ther · 2012 Match 98

    …that performance of non-invasive markers for liver fibrosis in hepatitis C…

    FibroTest HCV

  16. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Key publication

    European Association for Study of Liver et al. · J Hepatol · 2015 Match 98

    FibroTest Alcohol HBV HCV +3

  17. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.

    Sène D et al. · Clin Biochem · 2006 Match 98

    ### Objective And Methods We assessed the reliability of non-invasive biological scoring…

    ActiTest FibroTest HCV

  18. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

    Sebastiani G et al. · J Hepatol · 2006 Match 98

    …diagnostic performance of non-invasive markers of liver fibrosis by combining them…

    FibroTest HCV

  19. Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.

    El-Shabrawi MH et al. · Eur J Gastroenterol Hepatol · 2010 Match 98

    …cause of chronic hepatitis and hepatic fibrosis. Liver biopsy, because of its…

    ActiTest FibroTest HCV

  20. Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.

    Kim BK et al. · PLoS One · 2012 Match 97

    …and FibroTest (FT) are frequently used as non-invasive alternatives for fibrosis…

    FibroTest HBV

  21. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.

    Castéra L et al. · J Hepatol · 2010 Match 97

    ### Background & Aims Non-invasive assessment of liver fibrosis is a challenging area…

    FibroTest HCV

  22. Current Possibilities to Assess the Degree of Liver Fibrosis in Patients with Haemophilia Infected with HCV--Review.

    Kucharska M et al. · Adv Clin Exp Med · 2015 Match 97

    …and minimally invasive assessment of liver disease progression and classification of the…

    FibroTest HCV

  23. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.

    Chou R et al. · Ann Intern Med · 2013 Match 97

    …of liver biopsy. ### Data Extraction Investigators abstracted and checked study details and…

    FibroTest HCV

  24. Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.

    Usluer G et al. · Eur J Clin Microbiol Infect Dis · 2012 Match 97

    …of nine non-invasive serum biomarkers with liver biopsies to predict liver…

    FibroTest HCV

  25. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Review

    Moreno C et al. · J Hepatol · 2019 Match 97

    …Non-invasive biological tests have also been evaluated to assess liver fibrosis…

    FibroTest Alcohol

  26. Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.

    Mbaye PS et al. · PLoS One · 2011 Match 96

    …values. ### Methods LSM and liver fibrosis biochemical markers were performed on 225…

    FibroTest HBV

  27. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.

    Castera L · J Viral Hepat · 2009 Match 96

    …of liver biopsy (invasive procedure, sampling errors, inter-observer variability and nondynamic…

    FibroTest HBV HCV HIV

  28. Non-invasive diagnosis and follow-up of portal hypertension.

    Thabut D et al. · Clin Res Hepatol Gastroenterol · 2022 Match 96

    …chronic liver disease (cACLD) describes the spectrum of advanced fibrosis/cirrhosis in…

    FibroTest Alcohol HBV HCV +1

  29. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.

    Boursier J et al. · Am J Gastroenterol · 2011 Match 96

    …and improves the accuracy of the non-invasive diagnosis of liver fibrosis…

    FibroTest HCV

  30. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.

    Poynard T et al. · PLoS One · 2008 Match 96

    …strength of concordance between non-invasive estimates of liver fibrosis for the…

    FibroTest Alcohol HBV HCV +3

  31. Noninvasive evaluation of NAFLD.

    Castera L et al. · Nat Rev Gastroenterol Hepatol · 2013 Match 96

    …of NASH. Ultrasonography-based transient elastography can exclude advanced fibrosis and cirrhosis…

    ActiTest FibroTest NashTest SteatoTest +1

  32. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.

    Stibbe KJ et al. · Scand J Gastroenterol · 2011 Match 95

    …non-invasive tests increased the accuracy for detection of liver fibrosis to…

    FibroTest HBV HCV

  33. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.

    Sebastiani G et al. · Aliment Pharmacol Ther · 2011 Match 95

    …non-invasive fibrosis biomarkers may be influenced by aetiology of chronic liver…

    FibroTest HBV HCV HIV +1

  34. Noninvasive Assessment of Liver Fibrosis.

    Castera L · Dig Dis · 2015 Match 95

    …and progression of liver fibrosis with the risk of developing cirrhosis. Liver…

    FibroTest HBV HCV

  35. An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.

    Carlson JJ et al. · J Gastroenterol Hepatol · 2009 Match 95

    …of non-invasive testing strategies in the diagnosis of significant liver fibrosis…

    FibroTest

  36. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.

    Boursier J et al. · Liver Int · 2009 Match 95

    …accuracy of the non-invasive diagnosis of liver fibrosis and, consequently, markedly…

    FibroTest Alcohol HBV HCV +2

  37. The non-invasive assessment of hepatic fibrosis.

    Gheorghe G et al. · J Formos Med Assoc · 2021 Match 95

    …the necessity of non-invasive tools to detect and grade liver fibrosis.

    ActiTest FibroTest Alcohol HBV +2

  38. Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients.

    Crisan D et al. · Hepat Mon · 2012 Match 94

    …accuracy of non-invasive methods for the assessment of liver fibrosis stage.

    FibroTest HCV

  39. Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.

    Liu S et al. · PLoS One · 2011 Match 94

    …expensive and carries risks of complications. FibroTest is a non-invasive biomarker…

    FibroTest HCV

  40. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.

    Lemoine M et al. · J Acquir Immune Defic Syndr · 2019 Match 94

    …liver disease. Noninvasive tests of steatosis, nonalcoholic steatohepatitis (NASH), and fibrosis have…

    FibroTest NashTest SteatoTest HIV

  41. Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

    López Tórrez SM et al. · Front Nutr · 2024 Match 94

    …liver biopsy and aspartate aminotransferase-to-platelet ratio (APRI), fibrosis index-4…

    FibroTest Metabolic

  42. FibroMAX: towards a new universal biomarker of liver disease?

    Morra R et al. · Expert Rev Mol Diagn · 2007 Match 94

    …of chronic liver diseases: FibroTest (BioPredictive) for the quantitative assessment of fibrosis…

    ActiTest AshTest FibroTest NashTest +7

  43. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.

    Adams LA et al. · J Gastroenterol Hepatol · 2011 Match 94

    …hepatic fibrosis is prognostic of liver morbidity and mortality in non-alcoholic…

    FibroTest Metabolic

  44. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.

    Poynard T et al. · J Hepatol · 2012 Match 93

    …of fibrosis progression in chronic liver diseases and better identification of risk…

    FibroTest Alcohol HBV HCV +1

  45. Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.

    Halfon P et al. · Antivir Ther · 2009 Match 93

    …of antiviral treatment on non-invasive serological markers of liver fibrosis in…

    FibroTest HCV HIV

  46. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.

    Bottero J et al. · J Hepatol · 2009 Match 93

    …most accurate non-invasive biochemical scores for liver fibrosis assessment in HIV…

    FibroTest HBV HIV

  47. Prevalence of liver fibrosis and cirrhosis in 699 Moroccan patients with chronic hepatitis C.

    Bouayad A et al. · Pan Afr Med J · 2021 Match 93

    …prevalence of liver fibrosis and cirrhosis using a non-invasive blood test…

    ActiTest FibroTest HCV

  48. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.

    Harris R et al. · Lancet Gastroenterol Hepatol · 2017 Match 93

    …liver disease, with the use of non-invasive markers of liver fibrosis…

    FibroTest Other

  49. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. Key publication

    Ratziu V et al. · BMC Gastroenterol · 2006 Match 93

    …of non-invasive markers of fibrosis, validated in chronic viral hepatitis and…

    FibroTest Metabolic

  50. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.

    Said Y et al. · Tunis Med · 2010 Match 92

    …008] and the stage of fibrosis F0, F1, F2 [OR =3. 35…

    FibroTest HCV

  51. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

    Halfon P et al. · Am J Gastroenterol · 2006 Match 92

    …markers of fibrosis and activity for use as a non-invasive alternative…

    ActiTest FibroTest HCV

  52. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.

    Vilar-Gomez E et al. · J Hepatol · 2018 Match 92

    …higher risk of non-liver- and liver-related morbidity and mortality. More…

    FibroTest Metabolic

  53. Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience.

    Yakoob R et al. · Ann Gastroenterol · 2015 Match 92

    …advanced fibrosis and <10% for cirrhosis) and between ActiTest and LB. Specificity…

    ActiTest FibroTest HCV

  54. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

    Maor Y et al. · Haemophilia · 2006 Match 92

    …using non-invasive biomarkers without liver biopsy. One hundred and thirty-two…

    FibroTest HCV

  55. Personalized management of cirrhosis by non-invasive tests of liver fibrosis.

    Wong GL et al. · Clin Mol Hepatol · 2015 Match 92

    …of non-invasive tests of fibrosis allows accurate diagnosis of cirrhosis and…

    FibroTest Alcohol HBV HCV +1

  56. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

    Cacoub P et al. · J Hepatol · 2008 Match 91

    …non-invasive liver fibrosis biomarkers for the prediction of significant liver fibrosis.

    FibroTest HCV HIV

  57. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C.

    Zarski JP et al. · PLoS One · 2013 Match 91

    …in which fibrosis was evaluated by liver biopsy (Metavir) and tests: Fibrometer…

    FibroTest HCV

  58. Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C.

    Maor Y et al. · Haemophilia · 2010 Match 91

    …to improve evaluation of fibrosis by non-invasive methods. Fifty-seven hepatitis…

    FibroTest HCV

  59. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

    Degos F et al. · J Hepatol · 2010 Match 91

    ### Background & Aims The diagnostic accuracy of non-invasive liver fibrosis tests that…

    FibroTest HBV HCV HIV

  60. Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.

    Gangadharan B et al. · PLoS One · 2012 Match 91

    …for assessing liver fibrosis and no reliable non-invasive diagnostic approach is…

    FibroTest HCV

  61. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

    Festi D et al. · Aliment Pharmacol Ther · 2013 Match 91

    …NAFLD', 'non invasive method and NAFLD', 'transient elastography' and 'liver fibrosis'. The…

    SteatoTest

  62. Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.

    Zarski JP et al. · Liver Int · 2010 Match 90

    …of fibrosis by morphometry and changes in blood markers of fibrosis. ### Results…

    ActiTest FibroTest HCV

  63. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication

    Poynard T et al. · Gastroenterol Clin Biol · 2008 Match 90

    …aspects of the interpretation of non-invasive biomarkers in liver fibrosis. A…

    ActiTest FibroTest SteatoTest Alcohol +5

  64. Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis C (Letter)

    Match 90

    FibroTest HCV

  65. Meta-analyses of FibroTest diagnostic value in chronic liver disease.

    Poynard T et al. · BMC Gastroenterol · 2007 Match 90

    ### Background FibroTest (FT) is a biomarker of liver fibrosis initially validated in…

    FibroTest Alcohol HBV HCV +1

  66. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.

    European Association for the Study of the Liver (EASL) et al. · Obes Facts · 2016 Match 90

    FibroTest SteatoTest Metabolic

  67. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.

    Zarski JP et al. · J Hepatol · 2012 Match 90

    …Hepascore® perform best and similarly for diagnosis of significant fibrosis and cirrhosis.

    FibroTest HCV

  68. Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients.

    Salles N et al. · Gastroenterol Clin Biol · 2009 Match 89

    …of this study was to evaluate liver fibrosis using non-invasive methods…

    FibroTest

  69. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.

    Morali G et al. · Isr Med Assoc J · 2007 Match 89

    …system that allows quantification of liver fibrosis and inflammation. This test has…

    ActiTest FibroTest Alcohol HBV +1

  70. Hepatitis B: are non-invasive markers of liver fibrosis reliable?

    Castera L · Liver Int · 2014 Match 89

    …of fibrosis, has been challenged in the past decade by non-invasive…

    FibroTest HBV HCV

  71. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Key publication

    Halfon P et al. · Gastroenterol Clin Biol · 2008 Match 89

    …and non-alcoholic fatty liver disease (NAFLD). The primary aim of the…

    FibroTest Alcohol HBV HCV +2

  72. Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children.

    Rubio A et al. · J Pediatr Gastroenterol Nutr · 2009 Match 89

    …prevalence of signs of liver affection, and analyse the influence of the…

    FibroTest HIV

  73. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.

    Kim BK et al. · PLoS One · 2012 Match 89

    ### Background And Aims Diagnostic values of FibroTest (FT) for hepatic fibrosis have…

    FibroTest HBV

  74. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.

    Sturm N et al. · Liver Int · 2013 Match 88

    ### Background Liver fibrosis, now assessed by liver biopsy or using non-invasive…

    FibroTest HBV HCV

  75. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Key publication

    Nguyen-Khac E et al. · Aliment Pharmacol Ther · 2008 Match 88

    …Aims To assess Fibroscan for non-invasive diagnosis of asymptomatic liver fibrosis…

    FibroTest Alcohol

  76. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.

    Myers RP et al. · AIDS · 2003 Match 88

    …non-invasive index of biochemical markers for the prediction of fibrosis in…

    FibroTest HCV HIV

  77. The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.

    Sökücü S et al. · Scand J Infect Dis · 2010 Match 88

    …of fibrosis and/or activity, and decreases the need for a liver…

    ActiTest FibroTest HBV

  78. Guidelines for the diagnosis of uncomplicated cirrhosis.

    Fontaine H et al. · Gastroenterol Clin Biol · 2007 Match 88

    FibroTest Alcohol HBV HCV +2

  79. Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

    Poynard T et al. · BMJ Open · 2015 Match 88

    …awareness of liver disease and both the HCV campaign and DAA availability…

    ActiTest FibroTest Alcohol HBV +3

  80. Assessment of liver fibrosis: noninvasive means.

    Poynard T et al. · Saudi J Gastroenterol · 2008 Match 87

    …advantages and the limits of the available biomarkers of liver fibrosis. Among…

    FibroTest Alcohol HBV HCV +3

  81. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.

    Maor Y et al. · Haemophilia · 2007 Match 87

    Non-invasive biomarkers have gained popularity for estimating fibrosis stage. In our…

    FibroTest HCV

  82. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).

    Poynard T et al. · BMC Gastroenterol · 2010 Match 87

    ### Background FibroTest and elastography have been validated as biomarkers of liver fibrosis…

    FibroTest Alcohol HBV HCV +3

  83. Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

    Bignulin S et al. · Ann Hepatol · 2016 Match 87

    …a non-invasive tool used in the evaluation of liver fibrosis in…

    FibroTest HCV

  84. Biomarkers of liver fibrosis.

    Poynard T et al. · Adv Clin Chem · 2008 Match 87

    …advantages and the limits of the available biomarkers of liver fibrosis. Among…

    ActiTest FibroTest SteatoTest Alcohol +5

  85. Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics.

    Chrostek L et al. · Biomed Res Int · 2019 Match 87

    …markers of liver fibrosis: APRI, GAPRI, Forns, FIB-4, Age-Platelet, and…

    FibroTest Alcohol

  86. Altered serum N-glycomics in chronic hepatitis B patients.

    Gui HL et al. · Liver Int · 2010 Match 86

    …and is a non-invasive blood test for the diagnosis of liver…

    FibroTest HBV

  87. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.

    Sebastiani G et al. · Hepatology · 2009 Match 86

    …of liver biopsies. A third algorithm identified significant fibrosis and cirrhosis simultaneously…

    FibroTest HCV

  88. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.

    Leroy V et al. · J Hepatol · 2014 Match 86

    …The risk of underestimating significant fibrosis and cirrhosis is however greater in…

    FibroTest HBV HCV

  89. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients.

    Fidai A et al. · Front Cardiovasc Med · 2017 Match 86

    …children and adults. FibroTest results were suggestive of fibrosis regardless of time…

    FibroTest Other

  90. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data.

    Poynard T et al. · PLoS One · 2012 Match 86

    …performance of non-invasive markers of fibrosis (FibroTest), steatosis (SteatoTest) and steato…

    ActiTest FibroTest NashTest SteatoTest +1

  91. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.

    Poynard T et al. · J Hepatol · 2012 Match 86

    …of FibroTest and Fibroscan for the diagnosis of advanced fibrosis and cirrhosis…

    FibroTest HCV

  92. Noninvasive diagnosis in alcohol-related liver disease. Review

    Hadefi A et al. · Health Sci Rep · 2020 Match 85

    …Among the noninvasive surrogate markers and techniques used to detect liver fibrosis…

    FibroTest Alcohol

  93. Stage of liver fibrosis in patients with congenital bleeding disorders and infected with hepatitis C virus.

    Kucharska M et al. · Pol Arch Intern Med · 2017 Match 85

    …fibrosis assessment, and to analyze the influence of risk factors on liver…

    FibroTest HCV

  94. The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test.

    Gudowska M et al. · Adv Clin Exp Med · 2015 Match 85

    …of liver diseases was assayed by means of non-invasive biomarkers: fibrosis…

    ActiTest AshTest FibroTest NashTest +2

  95. Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?

    Gentile I et al. · Infez Med · 2014 Match 85

    …non-null rate of false negative for the diagnosis of liver cirrhosis…

    FibroTest HCV

  96. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.

    Laharie D et al. · Eur J Gastroenterol Hepatol · 2010 Match 85

    …found between liver stiffness and portal and/or sinusoidal fibrosis. In patients…

    FibroTest Other

  97. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.

    de Lédinghen V et al. · Aliment Pharmacol Ther · 2013 Match 85

    …of liver stiffness, non-invasive tests of liver fibrosis, and liver biopsy…

    FibroTest HBV

  98. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

    Leroy V et al. · J Hepatol · 2007 Match 84

    ### Background/Aims Non-invasive markers of liver fibrosis have recently been developed…

    FibroTest HCV

  99. Reproducibility of blood tests of liver fibrosis in clinical practice.

    Calès P et al. · Clin Biochem · 2008 Match 84

    …reproducibility of blood test for liver fibrosis: FibroMeter, Fibrotest, APRI and their…

    FibroTest Alcohol HBV HCV +1

  100. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

    Jacqueminet S et al. · Clin Gastroenterol Hepatol · 2008 Match 84

    …advanced fibrosis, cirrhosis, and liver cancer. We examined the efficacy of a…

    FibroTest SteatoTest Metabolic

  101. FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.

    Patel K et al. · World J Gastroenterol · 2011 Match 84

    …For F2-4, FS (n = 2055) had sensitivity and specificity of 0…

    FibroTest HCV

  102. Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest - comparison with histopathological assessment.

    Pokorska-Śpiewak M et al. · Clin Exp Hepatol · 2017 Match 84

    …Further studies on non-invasive methods to evaluate liver disease severity in…

    ActiTest FibroTest HBV HCV

  103. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.

    Grigorescu M et al. · J Gastrointestin Liver Dis · 2007 Match 84

    …and observance of the technical recommendations for the assays of biochemical markers…

    FibroTest HCV

  104. Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastography.

    Knop V et al. · Nutrition · 2019 Match 83

    …to evaluate dynamic changes of liver fibrosis and steatosis within 12 mo…

    FibroTest SteatoTest Other

  105. Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.

    Patel K et al. · Aliment Pharmacol Ther · 2016 Match 83

    …of fibrosis progression in chronic liver disease relies upon non-invasive tools…

  106. Relationship between the Fibrotest and portal hypertension in patients with liver disease.

    Thabut D et al. · Aliment Pharmacol Ther · 2007 Match 83

    …and the presence and degree of PHT in patients with liver disease…

    FibroTest Alcohol HBV HCV +2

  107. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.

    Munteanu M et al. · Aliment Pharmacol Ther · 2016 Match 83

    ### Background Blood tests of liver injury are less well validated in non…

    ActiTest FibroTest SteatoTest Metabolic

  108. Systematic review: Investigating the prognostic performance of four non-invasive tests in alcohol-related liver disease.

    Rhodes FA et al. · J Gastroenterol Hepatol · 2021 Match 83

    …and liver fibrosis stage is the best mortality predictor. Non-invasive tests…

    FibroTest Alcohol

  109. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

    Poynard T et al. · Comp Hepatol · 2004 Match 83

    …use of the biochemical markers of liver fibrosis (FibroTest) and necrosis (ActiTest…

    ActiTest FibroTest HCV

  110. Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C.

    Boursier J et al. · BMC Gastroenterol · 2011 Match 82

    …of detailed fibrosis classifications available for non-invasive tests and liver biopsy…

    FibroTest HCV

  111. Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.

    Elalfy MS et al. · Ann Hepatol · 2013 Match 82

    …Non invasive Liver FibroScan and Fibro-Test were reliable methods to assess…

    ActiTest FibroTest HCV

  112. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.

    Köksal İ et al. · Turk J Gastroenterol · 2018 Match 82

    …of non-invasive serum biomarkers, separately and in combinations, on liver fibrosis…

    FibroTest HCV

  113. Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B.

    Dezanet LNC et al. · Liver Int · 2021 Match 82

    …and every 6-12 months. From data on non-invasive liver fibrosis…

    FibroTest HBV HIV

  114. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus. Key publication

    Poynard T et al. · J Viral Hepat · 2009 Match 82

    …Similar impacts of ADV on liver fibrosis and activity were observed both…

    ActiTest FibroTest HBV

  115. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers.

    Brühl J et al. · Eur J Gastroenterol Hepatol · 2011 Match 82

    …Correlation of inflammatory markers and noninvasive liver fibrosis tests, respectively, was generally…

    FibroTest Other

  116. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Key publication

    Poynard T et al. · Comp Hepatol · 2005 Match 81

    …simple and non-invasive quantitative estimate of liver steatosis and may reduce…

    SteatoTest Alcohol HBV HCV +1

  117. Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.

    Laharie D et al. · J Hepatol · 2010 Match 81

    …Non-invasive methods for the diagnosis of liver fibrosis, such as transient…

    FibroTest Other

  118. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.

    Anastasiou J et al. · Eur J Gastroenterol Hepatol · 2010 Match 81

    ### Background The efficiency of transient elastography for the assessment of liver fibrosis…

    ActiTest FibroTest Alcohol HBV +3

  119. Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection.

    Shaheen AA et al. · HIV Clin Trials · 2008 Match 81

    …The prevalence of significant fibrosis and cirrhosis were 51% and 16%, respectively…

    FibroTest HCV HIV

  120. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.

    Bonnard P et al. · Am J Trop Med Hyg · 2010 Match 81

    …Elastometric thresholds were identified for significant fibrosis and cirrhosis. Combined use of…

    FibroTest HBV

  121. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. Key publication

    Munteanu M et al. · J Gastrointestin Liver Dis · 2008 Match 81

    ActiTest AshTest FibroTest NashTest +6

  122. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. Key publication

    Ngo Y et al. · PLoS One · 2008 Match 80

    …The use of FibroTest (FT) and ActiTest (AT), biomarkers of fibrosis and…

    ActiTest FibroTest HCV

  123. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B.

    Mallet V et al. · Aliment Pharmacol Ther · 2009 Match 80

    …a simple and inexpensive biomarker to delineate liver fibrosis in chronic hepatitis…

    FibroTest HBV

  124. Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.

    Sebagh M et al. · J Hepatol · 2012 Match 80

    …and non-invasive markers. They exerted an impact on immunosuppressive and antiviral…

    ActiTest FibroTest Alcohol HBV +4

  125. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.

    Bourliere M et al. · Aliment Pharmacol Ther · 2008 Match 80

    ### Background Non-invasive liver fibrosis scores such as Hepascore (HS) have been…

    FibroTest HCV

  126. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.

    Poynard T et al. · Antivir Ther · 2010 Match 80

    …and a control group. Meta-analysis of the percentage of fibrosis progression…

    ActiTest FibroTest HBV HCV +1

  127. The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy.

    Xu XY et al. · PLoS One · 2014 Match 80

    …for identification of HBV-related significant fibrosis and cirrhosis. FIB-4 has…

    FibroTest HBV

  128. Applicability and variability of liver stiffness measurements according to probe position.

    Ingiliz P et al. · World J Gastroenterol · 2009 Match 79

    ### Aim To investigate the liver stiffness measurement (LSM) applicability and variability with…

    FibroTest Alcohol HBV HCV +3

  129. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography.

    Corradi F et al. · Dig Liver Dis · 2009 Match 79

    …need of non-invasive validated methods to estimate liver fibrosis. ### Aim To…

    FibroTest HCV

  130. Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

    Lee S et al. · World J Gastroenterol · 2014 Match 79

    …assessment of liver fibrosis. However, the method is invasive, and is associated…

    FibroTest HBV

  131. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

    Sadler MD et al. · Can J Gastroenterol Hepatol · 2015 Match 79

    …with cystic fibrosis (CF). However, detection of CF-associated liver disease (CFLD…

    FibroTest Other

  132. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

    Stevenson M et al. · Health Technol Assess · 2012 Match 79

    …of four non-invasive tests for liver fibrosis [the Enhanced Liver Fibrosis…

    FibroTest Alcohol

  133. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.

    Poynard T et al. · J Hepatol · 2013 Match 79

    …of fibrosis 10years later, a disappointing 5% decrease in cirrhosis cases, and…

    FibroTest HCV

  134. FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B.

    Zeremski M et al. · BMC Gastroenterol · 2014 Match 78

    ### Background Noninvasive markers of liver fibrosis have not been extensively studied in…

    ActiTest FibroTest HBV

  135. Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

    Peta V et al. · World J Hepatol · 2025 Match 78

    …FibroTest-ActiTest facilitated the evaluation of both fibrosis and activity.

    ActiTest FibroTest AIH

  136. Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

    Poynard T et al. · Curr Hepat Rep · 2011 Match 78

    …In conclusion, FibroTest and LSM were the most validated biomarkers of fibrosis…

    FibroTest HBV

  137. FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.

    Salkic NN et al. · Am J Gastroenterol · 2014 Match 78

    …heterogenous meta-analysis for liver fibrosis and cirrhosis, respectively. The area under…

    FibroTest HBV

  138. Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.

    Naveau S et al. · Eur J Gastroenterol Hepatol · 2014 Match 78

    …was one of the first composite liver fibrosis markers. This study aims…

    FibroTest Alcohol

  139. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis.

    Gressner OA et al. · Clin Chim Acta · 2009 Match 78

    …non-invasive multiparametric tests for staging and grading of liver fibrosis. ### Methods…

    ActiTest FibroTest HCV

  140. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.

    Poynard T et al. · Aliment Pharmacol Ther · 2007 Match 77

    …prevalence of each fibrosis stage defining advanced and non-advanced fibrosis. ### Results…

    FibroTest HCV

  141. Editorial: FibroTest to predict liver-related mortality in NAFLD. Should this change the diagnostic algorithm in NAFLD?

    Bush AM et al. · Aliment Pharmacol Ther · 2018 Match 77

    FibroTest Metabolic

  142. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.

    Poynard T et al. · Clin Res Hepatol Gastroenterol · 2011 Match 77

    ### Background Two widely used biomarkers of fibrosis, FibroTest and liver stiffness measurement…

    FibroTest HCV

  143. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.

    Thabut D et al. · Liver Int · 2006 Match 77

    …value of FibroTest, a non-invasive marker of liver fibrosis, for the…

    FibroTest Alcohol HBV HCV

  144. Changes of non-invasive markers and FibroScan values during HCV treatment.

    Vergniol J et al. · J Viral Hepat · 2009 Match 77

    The recent advent of non-invasive methods for assessment of fibrosis allows…

    FibroTest HCV

  145. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).

    Poynard T et al. · J Hepatol · 2014 Match 77

    …FT) and transient elastography (TE) as markers of occurrence of cirrhosis without…

    ActiTest FibroTest HBV

  146. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.

    Wu FM et al. · J Heart Lung Transplant · 2017 Match 76

    …of hepatic fibrosis and did not predict cirrhosis. ### Conclusions Abnormal biomarkers of…

    FibroTest

  147. Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease.

    Voican CS et al. · Liver Int · 2017 Match 76

    …of TE for liver fibrosis in patients with excessive alcohol consumption and…

    FibroTest Alcohol

  148. Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.

    Munteanu M et al. · Clin Biochem · 2008 Match 76

    FibroTest Alcohol HBV HCV +1

  149. Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.

    de Lédinghen V et al. · Dig Liver Dis · 2012 Match 76

    …liver fibrosis amongst patients hospitalized for their diabetes, using non-invasive methods…

    FibroTest Metabolic

  150. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. Key publication

    Poynard T et al. · BMC Gastroenterol · 2006 Match 76

    …non-alcoholic fatty liver disease, NashTest, a simple and non-invasive biomarker…

    NashTest Metabolic

  151. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.

    Friedrich-Rust M et al. · J Thorac Cardiovasc Surg · 2008 Match 76

    …increased risk of developing liver fibrosis and liver cirrhosis. The risk increases…

    ActiTest FibroTest Other

  152. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?

    Castera L et al. · J Hepatol · 2007 Match 75

    FibroTest HCV

  153. Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis.

    Vermehren J et al. · Liver Int · 2012 Match 75

    …non-invasive, ultrasound-based method for the evaluation of liver fibrosis and…

    FibroTest Alcohol HBV HCV +3

  154. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.

    Friedrich-Rust M et al. · J Clin Gastroenterol · 2010 Match 75

    …of liver fibrosis received transient elastography and examinations for serum markers of…

    FibroTest SteatoTest Other

  155. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.

    Park MS et al. · Liver Int · 2015 Match 75

    …liver fibrosis. We investigated the prognostic role of the combined use of…

    FibroTest HBV

  156. Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B.

    Houot M et al. · Aliment Pharmacol Ther · 2016 Match 75

    …the diagnosis of advanced fibrosis and 86 for cirrhosis. In All-CB…

    FibroTest HBV HCV

  157. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.

    Lynch M et al. · JAMA Dermatol · 2014 Match 75

    …liver stiffness, and this result is an indirect measure of hepatic fibrosis…

    FibroTest Other

  158. The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis test.

    Munteanu M et al. · Am J Gastroenterol · 2011 Match 74

    FibroTest HCV

  159. Effective use of FibroTest to generate decision trees in hepatitis C.

    Lau-Corona D et al. · World J Gastroenterol · 2009 Match 74

    …fibrosis scores in clinical studies and improve our understanding of fibrosis progression.

    FibroTest HCV

  160. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.

    Więcek S et al. · Mediators Inflamm · 2020 Match 74

    …fibrosis, remodeling, apoptosis, and cholestasis. As a consequence, portal hypertension, cirrhosis, and…

    ActiTest FibroTest Other

  161. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.

    Vermehren J et al. · BMC Gastroenterol · 2012 Match 74

    …Our aim was to determine the prevalence of liver fibrosis and associated…

    FibroTest HCV HIV

  162. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

    Match 74

    FibroTest HBV

  163. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes.

    Sberna AL et al. · Diabet Med · 2018 Match 74

    …liver index score, non-alcoholic fatty liver disease fibrosis score, and SteatoTest…

    FibroTest NashTest Metabolic

  164. Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age.

    Poynard T et al. · BMC Gastroenterol · 2011 Match 73

    …validated biomarker of fibrosis. To assess the applicability rate and to reduce…

    ActiTest FibroTest Alcohol HBV +4

  165. Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.

    Dai CY et al. · J Hepatol · 2010 Match 73

    …Serum HCV RNA and non-invasive markers of fibrosis (FibroTest) were tested…

    FibroTest HBV HCV

  166. Optimization and robustness of blood tests for liver fibrosis and cirrhosis.

    Calès P et al. · Clin Biochem · 2010 Match 73

    ### Objectives To optimize the performance and feasibility of fibrosis blood tests and…

    FibroTest HCV

  167. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.

    Lewin M et al. · Hepatology · 2007 Match 73

    …coefficient (ADC) of water, for the diagnosis of liver fibrosis in patients…

    FibroTest HCV

  168. Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

    Perazzo H et al. · Clin Res Hepatol Gastroenterol · 2014 Match 73

    …of fibrosis, comparisons of APRI with other non-invasive tests, and estimates…

    FibroTest Alcohol HBV HCV +1

  169. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.

    Steininger K et al. · J Viral Hepat · 2017 Match 73

    …Liver fibrosis was estimated by Fibroscan^®^ and Fibrotest^®^ . Liver-related and non…

    FibroTest HCV HIV

  170. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.

    Bosselut N et al. · Clin Chim Acta · 2013 Match 72

    …Association between Fibroscan™ and Coopscore© might avoid 68% of liver biopsies for…

    FibroTest HCV

  171. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.

    Halfon P et al. · J Hepatol · 2007 Match 72

    …TPP) of blood tests of liver fibrosis. ### Methods Three hundred and fifty…

    FibroTest HCV

  172. Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis.

    Fierbinteanu-Braticevici C et al. · World J Gastroenterol · 2009 Match 72

    …accuracy for the assessment of liver fibrosis and was superior to other…

    FibroTest HCV

  173. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.

    Castéra L et al. · Aliment Pharmacol Ther · 2011 Match 72

    …significant fibrosis (F2 and F3) on liver biopsy. ### Conclusion Non-invasive tools…

    FibroTest HBV

  174. Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.

    Park MS et al. · PLoS One · 2013 Match 72

    …Here, we aimed to identify predictors of discordance between FT and liver…

    FibroTest HBV

  175. Prognostic value of liver fibrosis biomarkers: a meta-analysis.

    Poynard T et al. · Gastroenterol Hepatol (N Y) · 2011 Match 72

    …the diagnosis of fibrosis in patients with chronic liver disease. This paper…

    FibroTest Alcohol HBV HCV +3

  176. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia.

    Perazzo H et al. · Aliment Pharmacol Ther · 2014 Match 71

    …value of non-invasive biomarkers of liver fibrosis (FibroTest) and steatosis (SteatoTest…

    FibroTest SteatoTest Metabolic

  177. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Key publication

    Shiha G et al. · Hepatol Int · 2009 Match 71

    …to assess fibrosis. However, liver biopsy being invasive and, in many instances…

    FibroTest SteatoTest HBV HCV +1

  178. Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.

    Poynard T et al. · Clin Res Hepatol Gastroenterol · 2012 Match 71

    …of advanced fibrosis (EFT-F2) and one for the diagnosis of cirrhosis…

    Elasto-FibroTest FibroTest HCV

  179. Combination of fibrosis tests: sequential or synchronous?

    Boursier J et al. · Hepatology · 2009 Match 71

    FibroTest HCV

  180. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

    Boursier J et al. · Hepatology · 2012 Match 71

    …of significant fibrosis (SAFE or BA for Metavir F ≥ 2) or cirrhosis…

    FibroTest HCV

  181. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis.

    Poynard T et al. · Clin Gastroenterol Hepatol · 2012 Match 71

    …of biopsy analysis for intermediate-stage fibrosis and inappropriate determination of the…

    FibroTest Alcohol HBV HCV +3

  182. Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.

    Poynard T et al. · J Hepatol · 2013 Match 70

    …of reduced fibrosis progression and improved activity score. The safety profile of…

    ActiTest FibroTest HBV

  183. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients.

    Miailhes P et al. · J Viral Hepat · 2011 Match 70

    …fibrosis (≥ F3) and 0.96 for cirrhosis. Using a cut-off of…

    FibroTest HBV HIV

  184. Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.

    Tran A et al. · Clin Res Hepatol Gastroenterol · 2022 Match 70

    …non-invasive methods in screening, in assessing viral disease and liver fibrosis…

    FibroTest HCV

  185. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests.

    Calès P et al. · Gastroenterol Clin Biol · 2008 Match 70

    …cirrhosis. ### Conclusion The detection rate and PPV for cirrhosis using fibrosis scales…

    FibroTest HCV

  186. Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications.

    Boursier J et al. · Clin Gastroenterol Hepatol · 2023 Match 70

    ### Background & Aims Noninvasive tests (NITs) of liver fibrosis have been suggested to…

    FibroTest Metabolic

  187. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Key publication

    Naveau S et al. · Hepatology · 2009 Match 70

    …A total of 218 consecutive patients with ALD and available liver biopsy…

    ActiTest AshTest FibroTest Alcohol

  188. The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests.

    Netanel C et al. · Am J Surg · 2021 Match 69

    …Mean fibrosis, as measured by SWE liver stiffness and FibroTest™, did not…

    FibroTest NashTest SteatoTest Metabolic

  189. Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.

    Cheng J et al. · PLoS One · 2015 Match 69

    …However, the sensitivity, specificity and diagnostic accuracy in evaluating liver fibrosis of…

    FibroTest HBV

  190. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.

    Fernandez M et al. · Eur J Gastroenterol Hepatol · 2015 Match 69

    …the diagnosis of advanced fibrosis and cirrhosis in chronic liver disease. However…

    FibroTest Alcohol

  191. Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.

    Rudler M et al. · PLoS One · 2015 Match 69

    …AshTest is an appropriate non-invasive alternative to transjugular liver biopsy.

    AshTest Alcohol

  192. [Biomarkers for liver fibrosis: advances, advantages and disadvantages].

    Cequera A et al. · Rev Gastroenterol Mex · 2014 Match 69

    …determining non-invasive markers for the diagnosis of liver fibrosis, since at…

    FibroTest HCV

  193. Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.

    Meritsi A et al. · Clin Diabetes · 2022 Match 69

    ActiTest FibroTest NashTest-2 Metabolic

  194. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C.

    Zarski JP et al. · PLoS One · 2013 Match 68

    …in which fibrosis was evaluated by liver biopsy (Metavir) and tests: Fibrometer…

    FibroTest HCV

  195. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.

    Boursier J et al. · Eur J Gastroenterol Hepatol · 2009 Match 68

    …fibrosis and cirrhosis. ### Methods The accuracy for severe fibrosis or cirrhosis of…

    FibroTest HCV

  196. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure.

    Poynard T et al. · Gastroenterol Clin Biol · 2010 Match 68

    ### Background ActiTest (AT) is a biomarker of liver necro-inflammatory histological activity…

    ActiTest HCV

  197. A novel panel of blood markers to assess the degree of liver fibrosis.

    Calès P et al. · Hepatology · 2005 Match 68

    …In conclusion, the pathological staging and area of liver fibrosis can be…

    FibroTest Alcohol HBV HCV

  198. Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.

    Shlomai A et al. · J Viral Hepat · 2013 Match 68

    …infection and correlated these levels with the degree of liver fibrosis as…

    FibroTest HCV

  199. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.

    Beckebaum S et al. · Transplantation · 2010 Match 68

    …AUROCs for diagnosis of F> or =3 in HCV patients and non…

    FibroTest Alcohol HBV HCV +2

  200. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.

    Petit JM et al. · Liver Int · 2011 Match 67

    …liver fat content (LFC) and liver fibrosis independent of visceral adiposity and…

    FibroTest Metabolic

  201. LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.

    Poynard T et al. · Aliment Pharmacol Ther · 2019 Match 67

    …of primary liver cancer in patients without cirrhosis. ### Aim To construct and…

    FibroTest LCR1 LCR2 Alcohol +3

  202. Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.

    Sebastiani G et al. · Can J Gastroenterol Hepatol · 2014 Match 67

    …Routine assessment of liver fibrosis was requested by the surveyed physicians mostly…

    FibroTest Alcohol HBV HCV +3

  203. Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis.

    Friedrich-Rust M et al. · J Cyst Fibros · 2013 Match 67

    …be promising non-invasive methods for detection of liver-fibrosis in patients…

    FibroTest Other

  204. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.

    Grattagliano I et al. · Ann Hepatol · 2013 Match 67

    …fatty liver index (FLI) and an algorithm of nine serum markers (Fibromax…

    ActiTest FibroTest NashTest SteatoTest +1

  205. The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.

    Adler M et al. · Hepatology · 2008 Match 67

    FibroTest Alcohol HBV HCV +1

  206. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

    Calès P et al. · J Hepatol · 2010 Match 66

    …5 non-specific and 2 specific blood tests for liver fibrosis in…

    FibroTest HCV HIV

  207. Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

    Ofei SY et al. · Int J Cardiol · 2015 Match 66

    FibroTest Other

  208. [SWE elastography in assessment of liver fibrosis].

    Zaleska-Dorobisz U et al. · Postepy Hig Med Dosw (Online) · 2015 Match 66

    …assessment of liver fibrosis. However, due to its invasiveness and possible complications…

    FibroTest HBV HCV

  209. LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis. Key publication

    Poynard T et al. · Aliment Pharmacol Ther · 2019 Match 66

    …of primary liver cancer in patients without cirrhosis. ### Aim To construct and…

    LCR1 LCR2 Alcohol HBV +4

  210. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.

    Bonnard P et al. · J Viral Hepat · 2015 Match 66

    …to assess liver fibrosis in chronic hepatitis C (CHC) and is required…

    FibroTest HCV

  211. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

    Castéra L et al. · Gastroenterology · 2005 Match 66

    …The combined use of FibroScan and FibroTest to evaluate liver fibrosis could…

    FibroTest HCV

  212. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.

    Calès P et al. · Liver Int · 2008 Match 65

    …and improve the reliable diagnosis rates of blood tests for significant liver…

    FibroTest HCV

  213. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.

    Castéra L et al. · J Hepatol · 2009 Match 65

    …most accurate non-invasive method for early detection of cirrhosis in CHC…

    FibroTest HCV

  214. Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

    Poynard T et al. · Diagnostics (Basel) · 2025 Match 65

    …obesity, and liver fibrosis (resmetirom) announce the widespread use of fibrosis tests…

    FibroTest-T2D Metabolic

  215. Biomarkers for liver disease in urea cycle disorders.

    Nagamani SCS et al. · Mol Genet Metab · 2021 Match 65

    …potential utility of several non-invasive biomarkers for liver fibrosis in UCDs…

    ActiTest FibroTest Other

  216. Implementing non-invasive markers for liver fibrosis in clinical practice.

    Sebastiani G et al. · J Hepatol · 2008 Match 65

    FibroTest HCV

  217. Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis.

    Poynard T et al. · Aliment Pharmacol Ther · 2023 Match 65

    FibroTest-T2D NashTest-T2D SteatoTest-T2D Metabolic

  218. FibroTest (FT) has similar accuracy for cirrhosis in 'intention-to-diagnose' which is superior to transient elastography (TE) in chronic hepatitis B.

    Munteanu M et al. · Liver Int · 2014 Match 64

    FibroTest HBV

  219. Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.

    Crisan D et al. · Indian J Med Res · 2017 Match 64

    …and the association of this parameter with insulin resistance (IR) and liver…

    ActiTest FibroTest SteatoTest HCV

  220. Diagnostic algorithms for liver fibrosis in hepatitis C: are they ready to avoid liver biopsy?

    Sebastiani G et al. · Hepatology · 2012 Match 64

    FibroTest HCV

  221. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.

    de Lédinghen V et al. · J Pediatr Gastroenterol Nutr · 2007 Match 64

    …diagnosis of cirrhosis in children with chronic liver diseases. ### Patients And Methods…

    FibroTest HBV HCV Other

  222. Letter: APRI and FIB-4 do not correlate with Fibrosure in the evaluation of liver fibrosis in hepatitis C patients.

    Herman M et al. · Aliment Pharmacol Ther · 2017 Match 64

    FibroTest HCV

  223. Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard.

    Poynard T et al. · J Hepatol · 2013 Match 64

    …diagnosis of fibrosis as compared with FibroTest (FT) and liver stiffness measurement…

    FibroTest Alcohol HBV HCV +3

  224. Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.

    Friedrich-Rust M et al. · Ultraschall Med · 2009 Match 63

    …and FibroTest for the noninvasive assessment of liver fibrosis. ### Materials And Methods…

    FibroTest Alcohol HBV HCV +2

  225. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.

    Naveau S et al. · Clin Gastroenterol Hepatol · 2005 Match 63

    …of noninvasive markers of fibrosis in patients with chronic alcoholic liver disease…

    FibroTest Alcohol

  226. Management of the patient with SVR. Review

    Terrault NA et al. · J Hepatol · 2016 Match 63

    …reductions in rates of liver complications, hepatocellular carcinoma and mortality. Additional benefits…

    FibroTest HCV

  227. Spleen stiffness measurement by transient elastography to diagnose portal hypertension in children.

    Goldschmidt I et al. · J Pediatr Gastroenterol Nutr · 2014 Match 63

    …with established markers of liver fibrosis and parameters of portal hypertension. ### Methods…

    FibroTest Other

  228. Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease.

    Munteanu M et al. · Aliment Pharmacol Ther · 2013 Match 63

    FibroTest Metabolic

  229. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.

    Sagrini E et al. · Eur J Gastroenterol Hepatol · 2013 Match 63

    …of fibrosis (nil-mild, moderate, advanced/cirrhosis), using histology as reference, and…

    FibroTest HCV

  230. Non-invasive assessment of liver fibrosis: are we ready?

    Castera L et al. · Lancet · 2010 Match 62

    FibroTest Alcohol HBV HCV +1

  231. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

    Zelber-Sagi S et al. · World J Gastroenterol · 2013 Match 62

    …All subjects underwent anthropometric measurements and fasting blood tests. Evaluation of liver…

    SteatoTest Metabolic

  232. Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).

    Munteanu M et al. · Comp Hepatol · 2004 Match 62

    …These consisted of 29 healthy volunteers and 35 patients with chronic liver…

    ActiTest FibroTest Alcohol HBV +3

  233. EASL clinical practical guidelines: management of alcoholic liver disease.

    European Association for the Study of Liver · J Hepatol · 2012 Match 62

    FibroTest Alcohol

  234. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.

    Pais R et al. · Eur J Intern Med · 2015 Match 62

    …The prevalence of fibrosis≥F2 was 10% (CHB), 42% (CHC) and 21…

    FibroTest SteatoTest HBV HCV +1

  235. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

    de Lédinghen V et al. · Liver Int · 2012 Match 62

    …and fibrosis can be evaluated simultaneously, enlarging the spectrum of non-invasive…

    SteatoTest Metabolic

  236. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

    Poynard T et al. · Clin Chem · 2004 Match 61

    ### Background The FibroTest and ActiTest are noninvasive biochemical markers of liver injury…

    ActiTest FibroTest HCV

  237. Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.

    Chen SH et al. · BMC Gastroenterol · 2012 Match 61

    …and METAVIR A grades, explained the false positivity of liver fibrosis staging…

    FibroTest HCV

  238. Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.

    Poynard T et al. · Aliment Pharmacol Ther · 2021 Match 61

    …non-invasive diagnosis of the stages of fibrosis, and the grades of…

    FibroTest NashTest-2 SteatoTest Metabolic

  239. Toward non-invasive assessment strategies in autoimmune hepatitis.

    Jerez Diaz D et al. · World J Hepatol · 2025 Match 61

    …of standardized scoring for non-invasive testing, and the presence of inflammation…

    ActiTest FibroTest AIH

  240. Performance of the FibroTest cannot be accurately estimated in nine paediatric patients with advanced fibrosis.

    Munteanu M et al. · Scand J Infect Dis · 2011 Match 61

    ActiTest FibroTest HCV

  241. Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up.

    Calin R et al. · J Clin Virol · 2013 Match 61

    …of HBV-G on liver fibrosis progression, as assessed by a non…

    FibroTest HBV HIV

  242. Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.

    Munteanu M et al. · Aliment Pharmacol Ther · 2018 Match 60

    …the stage of fibrosis in non-alcoholic fatty liver disease (NAFLD) with…

    FibroTest Alcohol HBV HCV +1

  243. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.

    Viglino D et al. · Eur Respir J · 2017 Match 60

    …NASH) and liver fibrosis. Patients underwent an objective assessment of COPD comorbidities…

    FibroTest NashTest SteatoTest Metabolic

  244. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

    European Association for the Study of the Liver · J Hepatol · 2011 Match 60

    ActiTest FibroTest HCV

  245. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

    Boursier J et al. · J Hepatol · 2016 Match 60

    …the non-invasive diagnosis of liver fibrosis in NAFLD. LSM and FibroMeter…

    FibroTest Metabolic

  246. Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.

    Zarski JP et al. · Clin Res Hepatol Gastroenterol · 2020 Match 60

    ### Background And Aims Markers predicting complications of post-hepatitis C cirrhosis are…

    ActiTest FibroTest HCV

  247. Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?

    Poynard T et al. · Gastroenterology · 2005 Match 60

    ActiTest FibroTest Alcohol HBV +3

  248. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.

    Boursier J et al. · Aliment Pharmacol Ther · 2014 Match 59

    …for fibrosis and the other for cirrhosis, optimises assessment of liver-prognosis.

    FibroTest HCV

  249. FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?

    Poynard T et al. · Expert Rev Mol Diagn · 2005 Match 59

    …These include FibroTest (BioPredictive) for the quantitative assessment of fibrosis, and ActiTest…

    ActiTest FibroTest Alcohol HBV +2

  250. Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society.

    Petroff D et al. · Dig Liver Dis · 2018 Match 59

    FibroTest Metabolic

  251. Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.

    Cassinotto C et al. · Radiology · 2013 Match 59

    …Az of ARFI for cirrhosis and severe fibrosis = 0.92 and 0…

    FibroTest Alcohol HBV HCV +2

  252. [Prognosis assessment of alcoholic liver disease: how and why?].

    Trabut JB et al. · Presse Med · 2014 Match 59

    …A validation of non-invasive methods for ALD could allow a large…

    FibroTest Alcohol

  253. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

    Callewaert N et al. · Nat Med · 2004 Match 59

    …The current 'gold standard' for liver cirrhosis detection is an invasive, costly…

    FibroTest Alcohol Other

  254. Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation.

    Chen J et al. · J Clin Lab Anal · 2013 Match 58

    …The logistic regression equations for diagnosing liver fibrosis and early cirrhosis were…

    FibroTest HBV

  255. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

    Rosenthal-Allieri MA et al. · Gastroenterol Clin Biol · 2007 Match 58

    …Such discordance is of little clinical consequence for liver fibrosis evaluation in…

    ActiTest FibroTest HCV

  256. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.

    Minville C et al. · Chest · 2014 Match 58

    …The dose-response relationship between the severity of nocturnal hypoxia and liver…

    FibroTest NashTest SteatoTest Metabolic

  257. Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis.

    Haseltine EL et al. · J Viral Hepat · 2015 Match 58

    …However, not all correlations observed between noninvasive markers and fibrosis stage at…

    FibroTest HCV

  258. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.

    Thabut D et al. · J Hepatol · 2006 Match 58

    …and non-invasive quantitative estimate of alcoholic hepatitis. The use of AshTest…

    AshTest Alcohol

  259. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

    Myers RP et al. · Am J Gastroenterol · 2002 Match 58

    …a liver biopsy and serum tested for markers of fibrosis. The discriminative…

    FibroTest HCV

  260. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.

    Schleiger A et al. · Pediatr Cardiol · 2020 Match 57

    …corresponding to fibrosis stage ≥ 2. Liver stiffness values and Fibrotest^®^ scores correlated…

    FibroTest Other

  261. Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.

    Fontanges T et al. · Gastroenterol Clin Biol · 2008 Match 57

    …activity and fibrosis as compared with the histological analysis of liver biopsy…

    ActiTest FibroTest HCV

  262. Predicting significant fibrosis in hepatitis C patients in Luxembourg using serological markers.

    Mossong J et al. · Bull Soc Sci Med Grand Duche Luxemb · 2011 Match 57

    …number of biological markers putatively associated with liver fibrosis. Fibrotest and Forns…

    FibroTest HCV

  263. Poynard T, Ratziu V, Imbert-Bismut F, Munteanu M

    Match 57

    ActiTest FibroTest HCV

  264. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.

    Lassailly G et al. · Eur J Gastroenterol Hepatol · 2011 Match 57

    …utility of noninvasive markers of fibrosis (FibroTest), steatosis (SteatoTest), and steatohepatitis (NashTest…

    FibroTest NashTest SteatoTest Metabolic

  265. Analytical variability of the Fibrotest proteins.

    Rosenthal-Allieri MA et al. · Clin Biochem · 2005 Match 57

    …underwent liver biopsy. We compared measurements of haptoglobin, apolipoprotein A1 and alpha2…

    FibroTest HCV

  266. Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals.

    Istaces N et al. · Clin Biochem · 2015 Match 56

    …F2 and F3 liver fibrosis stages in non-alcoholic fatty liver disease…

    FibroTest HBV HCV

  267. Poynard T, Imbert-Bismut F, Ratziu V, Myers RP, Di Martino V, Thabut D, Moussalli J, Benhamou Y

    Match 56

    ActiTest FibroTest HCV

  268. Evaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis C.

    Awad Mel-D et al. · J Egypt Soc Parasitol · 2013 Match 56

    …of activity and progression of the chronic liver disease including METAVIER fibrosis…

    ActiTest FibroTest HCV

  269. Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.

    Wilson TG et al. · Int J Cardiol · 2018 Match 56

    …and 14.1 ± 7.6 years, respectively. Features suggestive of hepatic fibrosis…

    FibroTest Other

  270. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.

    Alric L et al. · Transpl Int · 2009 Match 56

    …Diagnosis of patients with severe liver fibrosis (F3/F4) by FT and…

    FibroTest HBV HCV

  271. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.

    Sebastiani G et al. · J Viral Hepat · 2008 Match 56

    …stage liver fibrosis. Specific noninvasive tools and possibly combination of markers should…

    FibroTest HCV

  272. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication

    Myers RP et al. · Can J Gastroenterol · 2012 Match 55

    …medical and economic burden in Canada, affecting nearly 1% of the population…

    FibroTest HCV

  273. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

    Vergniol J et al. · Gastroenterology · 2011 Match 55

    …chronic liver diseases, level of fibrosis predicts liver-related complications and survival…

    FibroTest HCV HIV

  274. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.

    Thiele M et al. · Gastroenterology · 2018 Match 55

    …fibrosis and cirrhosis and to determine whether combinations of fibrosis markers increase…

    FibroTest Alcohol

  275. Noninvasive Testing for Nonalcoholic Steatohepatitis and Hepatic Fibrosis in Patients With Psoriasis Receiving Long-term Methotrexate Sodium Therapy.

    Bauer B et al. · JAMA Dermatol · 2017 Match 55

    …noninvasive monitoring of the development and progression of hepatic fibrosis in patients…

    FibroTest NashTest

  276. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.

    Myers RP et al. · J Hepatol · 2003 Match 55

    …markers are accurate noninvasive markers of HBV-related activity and fibrosis, respectively.

    ActiTest FibroTest HBV

  277. Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.

    Fouad A et al. · Int J Gen Med · 2013 Match 55

    …infection and may be a major determinant of progression of liver injury…

    HCV

  278. Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.

    Brener S · Ont Health Technol Assess Ser · 2015 Match 54

    ### Background Liver fibrosis is a sign of advanced liver disease and is…

    Elasto-FibroTest FibroTest Alcohol HBV +3

  279. Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus.

    Varaut A et al. · Transplantation · 2005 Match 54

    …of significant fibrosis by comparison with liver biopsy was 71%, and an…

    FibroTest HCV

  280. American Association for the Study of the Liver

    Match 54

    FibroTest HCV

  281. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease.

    Halfon P et al. · Comp Hepatol · 2002 Match 54

    …Biochemical markers for liver fibrosis (FibroTest) and necroinflammatory features (ActiTest) are an…

    ActiTest FibroTest Alcohol HCV

  282. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

    Poynard T et al. · Hepatology · 2003 Match 54

    …of fibrosis and activity could be used as surrogate markers for liver…

    ActiTest FibroTest HCV

  283. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

    Poynard T et al. · J Hepatol · 2014 Match 54

    …and Transient Elastography (TE) have been validated as non-invasive markers of…

    FibroTest HCV

  284. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. Review

    Bril F et al. · Diabetes Care · 2017 Match 53

    …form of the disease, and increases the risk of cirrhosis and hepatocellular…

    FibroTest Metabolic

  285. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.

    Patel K et al. · J Viral Hepat · 2009 Match 53

    …markers that accurately follow changes in fibrosis may provide alternatives to liver…

    FibroTest HCV

  286. Impact of steatosis and inflammation definitions on the performance of NASH tests.

    Poynard T et al. · Eur J Gastroenterol Hepatol · 2018 Match 53

    …limitations of similar European (Fatty Liver Inhibition of Progression) and USA (Clinical…

    ActiTest FibroTest NashTest NashTest-2 +3

  287. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.

    Boyd A et al. · J Int AIDS Soc · 2017 Match 53

    …of this study was to evaluate the evolution of liver fibrosis and…

    FibroTest HBV HIV

  288. FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.

    Poynard T et al. · J Viral Hepat · 2008 Match 53

    FibroTest HCV

  289. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.

    White DL et al. · Hepatology · 2012 Match 53

    …The association between total testosterone and risk of advanced hepatic fibrosis (F3…

    ActiTest FibroTest HCV

  290. Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

    Jullian-Desayes I et al. · Respirology · 2016 Match 52

    …and severity of liver injury. ### Conclusion A number of non-invasive markers…

    NashTest SteatoTest Metabolic

  291. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.

    Imbert-Bismut F et al. · Clin Chem Lab Med · 2004 Match 52

    …The impact of parameter analytical variability on Fibrotest and Actitest results was…

    ActiTest FibroTest HCV

  292. Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab.

    Geri G et al. · J Viral Hepat · 2012 Match 52

    …severe HCV liver fibrosis and vasculitis. No beneficial effects of RTX were…

    FibroTest Alcohol HBV HCV +1

  293. Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia.

    Ratziu V et al. · Aliment Pharmacol Ther · 2007 Match 52

    …CONCLUSIONS The prevalence of fibrosis, steatosis and NASH in hyperlipidaemic patients appears…

    FibroTest NashTest SteatoTest Metabolic

  294. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.

    Castera L et al. · HIV Med · 2014 Match 52

    …Diagnostic accuracies for significant fibrosis (METAVIR F ≥ 2) and cirrhosis (F4) were…

    FibroTest HCV HIV

  295. Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.

    Poynard T et al. · Eur J Gastroenterol Hepatol · 2018 Match 52

    …than those of ActiTest, FIB4, BARD, and nonalcoholic fatty liver disease scores…

    FibroTest NashTest SteatoTest Metabolic

  296. Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.

    Deckmyn O et al. · Biomedicines · 2022 Match 51

    …ApoA1), and haptoglobin are associated with the risk of liver fibrosis, inflammation…

    FibroTest Metabolic

  297. Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes.

    Poynard T et al. · Eur J Gastroenterol Hepatol · 2020 Match 51

    …controls matched on gender, age, fibrosis stages and obesity, and taking into…

    FibroTest NashTest-2 SteatoTest-2 Metabolic

  298. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.

    Zelber-Sagi S et al. · Transl Res · 2015 Match 51

    …347) and, prospectively, in a subcohort of patients without fatty liver at…

    FibroTest SteatoTest Metabolic

  299. The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. Key publication

    Poynard T et al. · Eur J Gastroenterol Hepatol · 2019 Match 51

    …of the assessment of weight and height and in case of Gilbert…

    NashTest-2 SteatoTest-2 Metabolic

  300. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

    Terrault NA et al. · Hepatology · 2018 Match 51

    ActiTest FibroTest HBV

  301. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.

    Poinsot P et al. · J Clin Lipidol · 2017 Match 51

    …mean value of 40%. All children showed significant liver fibrosis (F3 [n…

    FibroTest Metabolic

Showing the full result list. The page is server-rendered and not paginated.